V aricella-zoster virus (VZV) is a neurotropic alphaherpesvirus that causes varicella (chickenpox), after which virus becomes latent in ganglionic neurons along the entire neuraxis. As VZVspecific cell-mediated immunity declines with age and in immunocompromised individuals, VZV reactivates to cause zoster (shingles) and other neurologic diseases (1, 2) .
Interferon gamma (IFN-␥) is a potent cytokine produced following primary VZV infection (3, 4) . Nonhuman primates experimentally infected with simian varicella virus (SVV), the counterpart of VZV, produce IFN-␥ 7 to 11 days postinfection (dpi) (5, 6) . IFN-␥ also inhibits herpes simplex virus 1 (HSV-1) infection in vitro (7) and in vivo (8) (9) (10) . Furthermore, VZV reactivation correlates with a decline of VZV-specific IFN-␥-producing immune cells (11) . VZV infection of human neurons in vitro is productive, although infected cells appear healthy 2 weeks later (12) (13) (14) . Here, we tested whether a cytopathic effect (CPE) eventually develops in VZV-infected neurons and, if so, whether IFN-␥ treatment suppresses viral growth and promotes neuronal survival after VZV infection.
Like ganglionic sensory neurons which express the IFN-␥ receptor on the cell surface (15) , immunofluorescent staining revealed that the induced pluripotent stem cell (iPSC)-derived neurons used in this study also expressed the IFN-␥ receptor (data not shown). To analyze the antiviral effects of IFN-␥, cultures were either pretreated with tissue culture medium containing 10 ng/ml IFN-␥ or left untreated, followed by infection the next day with VZV at a low multiplicity of infection (MOI; 0.001 to 0.0001; Zostavax; Merck) (14, 16, 17) for 3 h in the absence of IFN-␥. After infection, the inoculum was removed and replenished twice weekly for 14 days with medium containing or lacking 10 ng/ml IFN-␥. Immunofluorescence analysis for VZV immediate early (ORF63) and late (ORF68 and gE) proteins at 14 dpi revealed that IFN-␥ greatly reduced VZV spread in neurons (Fig. 1) .
Neurons infected with VZV at a low multiplicity of infection (Ͻ0.001) do not develop a CPE 14 dpi and are indistinguishable from uninfected neurons (12, 14) , despite extensive viral transcription (16), translation (12, 14) , and production of infectious virus (17) . However, by 28 dpi, a CPE did develop as evidenced by rounded cell bodies and retracted and fragmented neurites resembling a string of beads (Fig. 2, top panel) . In contrast, cells that were pretreated with IFN-␥, infected, and maintained in the presence of IFN-␥ for 28 days retained the healthy appearance of plump cell bodies and extended neurites (Fig. 2, bottom panel) , features of uninfected neurons (14) . Uninfected neurons treated with IFN-␥ for 28 days also maintained a healthy appearance and were indistinguishable from untreated cultures (data not shown).
The effects of IFN-␥ treatment on VZV replication and transcription were examined. Untreated and treated cells were infected, maintained as described above, and harvested at 28 dpi. DNA was extracted (GenElute; Sigma, St. Louis, MO) for quantification of viral genomes in 10 ng of total DNA using TaqManbased quantitative PCR (qPCR) targeted to a region within VZV ORF29 (Fig. 3 , left panel) as described previously (17) . At 28 dpi, IFN-␥-treated VZV-infected neurons contained 4.4-fold-fewer copies of VZV DNA than did untreated neurons. To analyze VZV transcripts, total RNA was harvested (mirVana; Ambion, Foster City, CA), and mRNA from 100 ng total RNA was bound to oligo(dT) beads (MACS; Miltenyi, Bergisch Gladbach, Germany), DNase treated (DNase I; Ambion), eluted, and reverse transcribed (Transcriptor First cDNA synthesis kit; Roche, Basel, Switzerland). Compared to untreated cultures, IFN-␥ treatment reduced the abundance of VZV transcripts ORF62 (5.4-fold), ORF63 (11.1-fold), ORF29 (5.6-fold), and ORF68 (7.3-fold), encompassing immediate early, early, and late kinetic classes (Fig. 3, right  panel) .
Production of infectious virus after IFN-␥ treatment was examined by releasing treated and untreated VZV-infected neurons with trypsin at 28 dpi. Neurons were then cocultivated with uninfected fibroblasts and observed for plaque formation. At 28 dpi, when a CPE developed in untreated neurons, 69 Ϯ 1 PFU were found, compared to 31 Ϯ 5 PFU in IFN-␥-treated cultures (Fig. 4) . Overall, IFN-␥ prolonged the life of VZV-infected neurons by inhibiting viral growth, reducing VZV genome content and transcript abundance, and decreasing production of infectious virus. To develop an in vitro model of VZV latency, future studies will examine the effects of other interferons (alpha and beta) as well as additional cytokines on VZV-infected neurons.
